Article

QC Ware has developed Promethium, a molecular design software for the pharmaceutical and materials industries, achieving over $1 million in bookings within its first year and attracting nearly 30 top-tier clients, including nine of the top 20 pharma companies. The company aims to innovate molecule development through fully 'in silico' methods, addressing complex simulation problems that competitors cannot solve, with a total addressable market estimated at $2 billion. Additionally, the Q2B Conference supports quantum startups and enhances visibility in the quantum technology sector.